By Dr María Perelló (Daiichi Sankyo Spain)2024-09-16T10:00:50
We had the privilege of talking to María Perelló, Medical Director at the Oncology Business Unit at Daiichi Sankyo Spain. As a gynaecologist, with a PhD in Endometriosis and an Executive MBA, she has many years of experience in the pharma industry as Medical Advisor, Medical Manager and Therapeutical Area ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-08-28T10:00:24Z
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-04T10:05:58
Sponsored by Revvity
2023-03-23T14:46:21
Sponsored by Bio-Techne
2024-02-08T11:07:39
Sponsored by Samplix ApS
2023-04-04T15:03:09
Sponsored by Agilent
2023-05-03T15:39:23
Sponsored by BPS Bioscience
Site powered by Webvision Cloud